Meroponia

Meropenem, the active ingredient in Meroponia, is a carbapenem presented as a injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, ventilator‑associated pneumonia, complicated urinary tract infections and sepsis in hospitalized patients.

GNH USA supplies Meroponia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meroponia is a carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

Complicated intra‑abdominal infections: effective bacterial eradication in patients with severe intra‑abdominal infection. Hospital‑acquired pneumonia: rapid clearance of pathogenic bacteria in nosocomial lung infections. Ventilator‑associated pneumonia: treatment of ventilator‑related pulmonary infections. Complicated urinary tract infections: resolves infections resistant to other agents. Sepsis: broad‑spectrum coverage for systemic bacterial infection.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Headache - Infusion site phlebitis - Elevated liver enzymes

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reactions - Seizures, especially in patients with CNS disorders - Clostridioides difficile‑associated colitis - Acute renal impairment - Thrombocytopenia - Severe neutropenia

Meroponia requires careful monitoring in several clinical situations. - Renal function: adjust dose in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy. - Seizure risk: monitor patients with a history of CNS disorders. - Superinfection: watch for fungal or C. difficile overgrowth during therapy. - Pregnancy and lactation: safety unknown; use only if benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meroponia may interact with several concomitant medications.

Major Interactions (Avoid): - Valproic acid: increased risk of seizures. - Probenecid: may reduce renal clearance of meropenem. - Nephrotoxic agents (e.g., aminoglycosides): additive renal toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR for possible potentiation. - Oral contraceptives: may have reduced effectiveness; consider alternative contraception.